Efficacy and Safety of Halobetasol Propionate 0.01% Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials

Main Article Content

F Cook-Bolden
J Soung
ST Guenthner
B Bumpass
T Lin

Keywords

Halobetasol, Psoriasis

Abstract

Abstract not available.

References

1. Nestle FO, et al. N Engl J Med. 2009;361(5):496-509.
2. Gottlieb AB, et al. Int J Womens Dermatol. 2019;5(3):141-150.
3. Menter A, et al. J Am Acad Dermatol. 2009;60(4):643-659.
4. Sugarman JL, et al. Cutis. 2019;103(2):11-116.
5. Green LJ, et al. J Drugs Dermatol. 2018;17(10):1062-1069.